LAG-3 is expressed on the cell membranes of tumor-infiltrating lymphocytes (TILs), activated CD4+ and CD8+ T cells, and regulatory T cells (Tregs), where it binds to MHC-II molecules on antigen-presenting cells (29). This evidence concerns the gene CD8A and neoplasm.